# The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function

> **NCT04043026** · — · TERMINATED · sponsor: **University of Liverpool** · enrollment: 56 (actual)

## Conditions studied

- Atrial Fibrillation
- Chronic Kidney Disease

## Interventions

- **DRUG:** Statin

## Key facts

- **NCT ID:** NCT04043026
- **Lead sponsor:** University of Liverpool
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-26
- **Primary completion:** 2022-08-01
- **Final completion:** 2022-08-01
- **Target enrollment:** 56 (ACTUAL)
- **Why stopped:** Slow recruitment due to COVID19 pandemic
- **Last updated:** 2022-08-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04043026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04043026, "The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04043026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*